Aspen Technology Inc (AZPN.OQ)
26 Dec 2014
|Market Cap (Mil.):||$3,346.53|
|Shares Outstanding (Mil.):||90.47|
JOHANNESBURG, Dec 24 - South Africa will spend 10 billion rand ($860 million) between 2015 and 2017 on life-prolonging HIV/AIDS treatment drugs, health authorities said on Wednesday, as studies show the prevalence of the virus is rising.
JOHANNESBURG, Sept 10 - Aspen Pharmacare is to sell the rights to market a blood clot drug in the United States to rival Mylan Inc for up to $300 million, it said on Wednesday, a move that would help Africa's top generic drugmaker pay down debt.
|Yokogawa Electric Corporation (6841.T)||¥1,387||+26.00|
|Siemens AG (SIEGn.DE)||€94.59||+0.78|
|ABB India Ltd (ABB.NS)||Rs1,202.65||+3.85|
|Oracle Corporation (ORCL.N)||$46.10||-0.11|
|Honeywell International Inc. (HON.N)||$101.63||-0.33|
|Rockwell Automation (ROK.N)||$113.01||+0.08|
|Invensys Ltd (ISYS.L)||--||--|
|Jda Software Group Inc (JDAS.OQ)||--||--|
|KBC Advanced Technologies Plc (KBCAT.L)||83.00p||+0.50|
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Trading Report for (AZPN). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ASPEN TECHNOLOGY INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
"The Economy Matters" Report for AZPN: the economy's impact on AZPN's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score
Provider: MacroRisk Analytics/EconomicInvestor
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.